Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
November 18, 2010

Lonza and CPRI Ally on Peptide Manufacturing and Development Services

  • Lonza and California Peptide Research (CPRI) are joining forces to more effectively serve customers requesting peptide manufacturing and development services. CPRI’s high-quality small-scale services will complement Lonza's capabilities in custom cGMP peptide manufacturing and development.

    The alliance aims at providing customers with a more complete offering that spans research through to commercial supply. It will also enable a seamless transition of custom peptide projects between CPRI’s small-scale facility and Lonza’s cGMP facilities.

    Based in San Franciscon, CPRI's customer base in North America will add to Lonza's existing facilities in Braine-l'Alleud (Belgium), Visp (Switzerland), Nansha (China), and Kourim (Czech Republic).

  • You’re all set! Thank you for subscribing to GEN Highlights.